By A Staff Reporter
Kathmandu, Feb. 25: The use of Remdesivir, an antiviral drug, has been found effective in treating COVID-19 patients in Nepal, according to a study conducted by Nepal Health Research Council (NHRC).
The study conducted by NHRC shows that Remdesivir has been successful in treating COVID-19 patients as 84 per cent of the patients – moderate and serious ones – recovered and were discharged after getting the antiviral drug.
“Of the patients given the antiviral drug, at least 84 per cent recovered from COVID-19,” according to the statement issued by the NHRC.
A total of 1,315 patients from 30 hospitals were enrolled in the study. Around 71.1 per cent patients were from Bagmati Province, 12.8 per cent patients were from Lumbini and 7.1 per cent patients recovered with the use of Remdesivir in Province 2.
Likewise, the NHRC also studied the use of convalescent plasma therapy on COVID-19 patients. Of the total 1,315 patients enrolled in the study, 83.6 per cent received Remdesivir alone, 5.8 per cent received convalescent plasma alone, and 10.6 per cent received both Remdesivir and convalescent plasma.
“Of all patients, 74 per cent patients were discharged in good condition, 4.4 per cent had some side effects, while 21.6 per cent patients died,” read the statement.